It is not just sleep or stress. It is the silent accumulation of daily decisions that could be defining which neurological, metabolic, or psychiatric disease your brain will develop in ten years. By Ehab Soltan HoyLunes — Contemporary neuroscience is forcing a revision of one of the most persistent ideas in medicine and popular culture: the notion of…
Read More
When patient data is generated outside the system, healthcare loses clinical control, medical time, and strategic advantage—and no company in the sector remains on the sidelines. By Ehab Soltan HoyLunes — The European healthcare system is beginning to fail in silence. Not due to a lack of resources, nor an absence of innovation, but because of a structural incapacity…
Read More
While artificial intelligence promises to extend human life, a silent fracture emerges: not everyone will access that longevity. The real disruption is not medical, it is structural. By Ehab Soltan HoyLunes — Historically, longevity was presented as a collective conquest. Vaccines, antibiotics, healthcare systems: advances designed to raise the life expectancy of entire populations. Progress, at least in…
Read More
It is not how much you sleep, but when you do it: the misalignment between the internal clock and modern life could be driving specific diseases —differently according to sex and age— without the healthcare system measuring it. By Ehab Soltan HoyLunes – For years, medicine and popular wisdom have reduced sleep to a purely quantitative variable: hours.…
Read More
Daily decisions—not clinical diagnoses—are redrawing the map of foot pathologies in women. Meanwhile, prevention remains the great ghost of the healthcare system and a lost opportunity for a market blind to real biomechanics. By Ehab Soltan HoyLunes – Historically, women’s health has been narrated through great biological epics: the hormonal revolution, nutrition paradigms, mental health, or the cult of…
Read More
In a market dominated by science, perception, and regulation, consumer trust has become the primary risk—and the most unstable asset—of the sector. By Ehab Soltan HoyLunes – For decades, the cosmetics industry has built its empire on a foundation of aspiration and rigor. Success has been cemented by an implicit promise: visible efficacy backed by science. Time-defying creams,…
Read More
From grape residues to high-performance materials, Vegea’s GrapeSkin challenges the foundations of luxury, proving that scalability, consistency, and environmental accountability can coexist under real industrial conditions. By Ehab Soltan HoyLunes – In the global materials industry, a structural shift is unfolding—quietly, but with far-reaching implications. For decades, luxury was defined by extraction: rare resources, animal-derived materials, and processes built…
Read More
Alberto Enguita, CEO of ClinicSay, analyzes how the convergence of Flexible Management Software and Specialized Artificial Intelligence is transforming operational efficiency, the dignity of healthcare work, and the economic sustainability of the sector. By Ehab Soltan In the debate on the sustainability of the European healthcare system, the conversation usually focuses on financing, talent, or infrastructure. However, there is…
Read More
The petcare industry is sliding toward a paradigm shift where the convergence of biological data, genomics, and animal behavior promises something audacious: deciphering the individual’s health long before disease appears. By Ehab Soltan HoyLunes (Analysis | Health and Transformation of the Pet Sector) For decades, the maturity of the animal nutrition market has been audited using linear and visible…
Read More
Inflammation, stress, and environment could be transforming hearing into an early biomarker of general health. By Ehab Soltan HoyLunes – For centuries, medicine has confined the human ear to the exclusive realm of sensory perception and communication; an instrument shaped by anatomy, the physics of sound, and neurology. In conventional clinical practice, its role has been, at best,…
Read More